ArticleNature2016
Snakebites: costing recombinant antivenoms.
Article in Nature, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed.
- Engineering Antivenom: Research Progress and Future Directions in Snakebite Envenoming Therapy.Annals of the New York Academy of Sciences · 2026Review
- Review
- Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach.Frontiers in microbiology · 2023Review
- Article
- Reassessing therapeutic antibodies for neglected and tropical diseases.PLoS neglected tropical diseases · 2020Review
- Cost of Manufacturing for Recombinant Snakebite Antivenoms.Frontiers in bioengineering and biotechnology · 2020Article
- Biosynthetic Oligoclonal Antivenom (BOA) for Snakebite and Next-Generation Treatments for Snakebite Victims.Toxins · 2018Article
- Review
- Article
- Snakebite: An Exploratory Cost-Effectiveness Analysis of Adjunct Treatment Strategies.The American journal of tropical medicine and hygiene · 2018Article
- Integrating Engineering, Manufacturing, and Regulatory Considerations in the Development of Novel Antivenoms.Toxins · 2018Article
- Basics of Antibody Phage Display Technology.Toxins · 2018Review
- Recent Advances in Next Generation Snakebite Antivenoms.Tropical medicine and infectious disease · 2018Review
- A synthetic biology approach for consistent production of plant-made recombinant polyclonal antibodies against snake venom toxins.Plant biotechnology journal · 2018Article
- Recombinant snakebite antivenoms: A cost-competitive solution to a neglected tropical disease?PLoS neglected tropical diseases · 2017Article
- Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
27708295What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.